Atlas Trials

Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males

Clinical trial NCT06509139 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06509139
Sponsor
National Cheng-Kung University Hospital
Status
ENROLLING_BY_INVITATION
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori InfectionSexBismuth Quadruple Therapy
Start date
2024-07-09
Primary completion
2032-07-31
Enrollment
661

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.